APA (7th ed.) Citation

S, D., M, M., MS, K., L, H., & A, E. (2026). Defining Safe and Effective Cefazolin Dosing Regimens for MSSA Infections in the CNS: Leveraging Sparse Real-World Data and PBPK Modeling. European journal of drug metabolism and pharmacokinetics, 51(2), 193. https://doi.org/10.1007/s13318-025-00981-0

Chicago Style (17th ed.) Citation

S, Dubinsky, McIntyre M, Kim MS, Hawryluk L, and Edginton A. "Defining Safe and Effective Cefazolin Dosing Regimens for MSSA Infections in the CNS: Leveraging Sparse Real-World Data and PBPK Modeling." European Journal of Drug Metabolism and Pharmacokinetics 51, no. 2 (2026): 193. https://doi.org/10.1007/s13318-025-00981-0.

MLA (9th ed.) Citation

S, Dubinsky, et al. "Defining Safe and Effective Cefazolin Dosing Regimens for MSSA Infections in the CNS: Leveraging Sparse Real-World Data and PBPK Modeling." European Journal of Drug Metabolism and Pharmacokinetics, vol. 51, no. 2, 2026, p. 193, https://doi.org/10.1007/s13318-025-00981-0.